This site is intended for healthcare professionals
Journals
  • Home
  • /
  • Journals
  • /
  • Hodgkin's disease
  • /
  • Distinct Hodgkin lymphoma subtypes defined by noni...
Journal

Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling

Read time: 1 mins
Published:1st Jan 2024
Author: Alig SK, Shahrokh Esfahani M, Garofalo A, Li MY, Rossi C, Flerlage T et al.
Source: Nature
Availability: Pay for access, or by subscription
Ref.:Nature. 2024 Jan;625(7996):778-787.
DOI:10.1038/s41586-023-06903-x
Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling 


The scarcity of malignant Hodgkin and Reed-Sternberg cells hampers tissue-based comprehensive genomic profiling of classic Hodgkin lymphoma (cHL). By contrast, liquid biopsies show promise for molecular profiling of cHL due to relatively high circulating tumour DNA (ctDNA) levels1-4. Here we show that the plasma representation of mutations exceeds the bulk tumour representation in most cases, making cHL particularly amenable to noninvasive profiling. Leveraging single-cell transcriptional profiles of cHL tumours, we demonstrate Hodgkin and Reed-Sternberg ctDNA shedding to be shaped by DNASE1L3, whose increased tumour microenvironment-derived expression drives high ctDNA concentrations. Using this insight, we comprehensively profile 366 patients, revealing two distinct cHL genomic subtypes with characteristic clinical and prognostic correlates, as well as distinct transcriptional and immunological profiles. Furthermore, we identify a novel class of truncating IL4R mutations that are dependent on IL-13 signalling and therapeutically targetable with IL-4Rα-blocking antibodies. Finally, using PhasED-seq5, we demonstrate the clinical value of pretreatment and on-treatment ctDNA levels for longitudinally refining cHL risk prediction and for detection of radiographically occult minimal residual disease. Collectively, these results support the utility of noninvasive strategies for genotyping and dynamic monitoring of cHL, as well as capturing molecularly distinct subtypes with diagnostic, prognostic and therapeutic potential.


Read abstract on library site  Access full article